期刊文献+

琥乙红霉素缓释片的处方工艺及其对释放度影响的研究 被引量:2

Study on Formulation and Preparation Procedure of Erythromycin Ethylsuccinate Sustained-release Tablets and Their Influence on Drug Release
下载PDF
导出
摘要 目的:研制琥乙红霉素缓释片并考察处方工艺对释放度的影响。方法:采用单因素方法考察不同辅料对琥乙红霉素缓释片释放度的影响,并通过正交试验设计,优化处方工艺。结果:优选工艺为:以羟丙甲基纤维素(用量为16%)为缓释骨架材料,乳糖(用量为14%)为填充剂,5%的HPMC(50%乙醇溶液)为黏合剂。释放度研究结果表明,琥乙红霉素缓释片释放度符合规定。结论:筛选优化的制备工艺稳定可控,重复性好。 Objective: To study the formulation and preparation of erythromycin ethylsuccinate sustained-release tablets and their influence on drug release. Method: The release behaviors of erythromycin ethylsueeinate sustained-release tablets were investigated by single factor study. The formulation and preparation procedure were optimized by orthogonal design. Result: HPMC and lactose were se- lected as the excipients of erythromyein ethylsuceinate sustained-release tablets. The results of dissolution in vitro showed that the drug release profile met the requirement. Conclusion: The selected preparation technique is stable and controllable with promising manufac- turing reproducibility.
出处 《中国药师》 CAS 2011年第11期1609-1612,共4页 China Pharmacist
关键词 琥乙红霉素 缓释片 处方工艺 累积释放度 Erythromycin ethylsuccinate Sustained-release tablets Formulation and preparation technique Accumulative release
  • 相关文献

参考文献6

二级参考文献35

  • 1王琳,程刚,郝秀华,文力奇,安峰,邵昌.甲氧氯普胺速释层与萘普生钠缓释层双层片的处方筛选及优化[J].中国药学杂志,2004,39(6):439-441. 被引量:6
  • 2冯婉玉.双嘧达莫临床药理新作用[J].中国医药情报,1995,1(4):243-246. 被引量:2
  • 3马瑜红.双嘧达莫的临床新用途[J].实用诊断与治疗杂志,2005,19(9):660-662. 被引量:6
  • 4洪燕龙,冯怡,徐德生.关于缓控释制剂的处方优化指标[J].中国中药杂志,2006,31(1):15-17. 被引量:22
  • 5ANDREW S W, LARRY W K, STEPHEN M P,et al. New roles for an old drug: Inhibition of gene expression by dipyridamole in platelet-lewkocyte aggregates [ J ]. Trends Cardiovasc Med , 2006,16 ( 3 ) : 75 - 80.
  • 6国家食品药品监督管理局.双嘧达莫缓释胶囊.国家药品标准[S].WS1-(X-168)-2003Z
  • 7国家食品药品监督管理局.阿司匹林双嘧达莫缓释片.国家药品标准[S].YBH38052005
  • 8Kolter K, Raunhofer WF, Ruchatz F. Properties of Kollidon SR as a new exeipient for sustained release dosage forms [J]. BASF Ex Act, 2001, (6) :5-7.
  • 9Markham A, Faulds D. Roxithromycin. An update of its anti microbial activity, pharmacokinetic properties and therapeutic use[J]. Drugs, 1994,48(2) :297-326.
  • 10唐星,于叶淼,任廷成,等.骨架型罗红霉素缓释微丸胶囊.CN101224217A[P].2008-07-23.

共引文献365

同被引文献16

  • 1Redon C, Lopez C. Betahistine treatment improves the recovery of static symptoms in patients with unilateral vestibular loss [ J ]. The Journal of Clinical Pharmacology,2011,51 (4) :538-548.
  • 2Sweetman SC. Martin D. The complete drug reference [ M]. 36nd ed. London : Pharmaceutical Press,2009.1174-1175.
  • 3Iqubal MK, Sharma DK. Development and optimization of betahistine dihydrochloride tablets by direct compression in different environ- mental condition [ J ] . Novel Science International Journal of Pharma- ceutical Science, 2012, 1 (11-12) :764 -770.
  • 4陈晓丹.川芎嗪自微乳化缓释固体分散体的研制[D].广州:广州中医药大学硕士学位论文,2010.
  • 5Siepmann J, Peppas NA. Modeling of drug release from delivery sys- tems based on hydroxypropyl methylcellulose ( HPMC ) [ J ]. Ad- vanced Drug Delivery Reviews, 2001,48 ( 2-3 ) : 163-174.
  • 6UrosK, Bostjan M. A novel beads-based dissolution method for the in vitro evaluation of extended release HPMC matrix tablets and the cor- relation with the in vitro data[ J]. AAPS Journal,2013,15 (1) :267- 276.
  • 7Hiroyuki M,Yutaka O,Masato I,et al.Formulation Approach for nicorandil pulsatile release tablet[J].Chem Pharm Bull,2008,56(4):464-467.
  • 8Abdelbary GA,Tadros MI.Design and in vitro/in vivo evaluation of novel nicorandil extended release matrix tablets based on hydrophilic interpolymer complexes and a hydrophobic waxy polymer[J].Eur J Pharm Biopharm,2008,69(1):1019-1028.
  • 9Rahman N,Khan NA,Hejaz Azmi SN.Optimized and validated spectrophotometric methods for the determination of nicorandil in drug formulations and biological fluids[J].Farmaco,2004,59(2):519-527.
  • 10Shamma RN,Basalious EB,Shoukr i RA.Development and optimization of a multiple-unit controlled release formulation of a freely water soluble drug for once-daily administration[J].Int J Pharm,2011,405(1):102-112.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部